Arrowhead Pharmaceuticals (ARWR) Goodwill & Intangibles (2016 - 2025)
Arrowhead Pharmaceuticals (ARWR) has disclosed Goodwill & Intangibles for 16 consecutive years, with $6.9 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Goodwill & Intangibles fell 19.87% year-over-year to $6.9 million, compared with a TTM value of $6.9 million through Sep 2025, down 19.87%, and an annual FY2025 reading of $6.9 million, down 19.87% over the prior year.
- Goodwill & Intangibles was $6.9 million for Q3 2025 at Arrowhead Pharmaceuticals, down from $7.3 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $14.5 million in Q1 2021 and bottomed at $6.9 million in Q3 2025.
- Average Goodwill & Intangibles over 5 years is $11.2 million, with a median of $12.0 million recorded in 2022.
- The sharpest move saw Goodwill & Intangibles decreased 10.49% in 2021, then fell 19.87% in 2025.
- Year by year, Goodwill & Intangibles stood at $13.2 million in 2021, then fell by 9.64% to $12.0 million in 2022, then fell by 14.21% to $10.3 million in 2023, then decreased by 16.57% to $8.6 million in 2024, then dropped by 19.87% to $6.9 million in 2025.
- Business Quant data shows Goodwill & Intangibles for ARWR at $6.9 million in Q3 2025, $7.3 million in Q2 2025, and $8.6 million in Q3 2024.